Related Experiment Video

Updated: Aug 26, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.5K

Effects of COVID-19 on Pediatric Cancer Care: A Multicenter Study of 11 Middle Eastern Countries

Mahmoud M Elzembely1,2, Abdulhakim Al Rawas3, Abdulqader Al-Hebshi4

  • 1Pediatric Oncology Department, South Egypt Cancer Institute, Assiut University.

Journal of Pediatric Hematology/Oncology
|October 11, 2022
PubMed

Insights

The COVID-19 pandemic significantly disrupted pediatric cancer care, impacting access and treatment continuity. Pediatric oncologists anticipate increased telemedicine use and potential chemotherapy protocol changes.

Area of Science:

  • Oncology
  • Public Health
  • Infectious Diseases

Background:

  • The COVID-19 pandemic presented unprecedented challenges to pediatric cancer centers globally.
  • Disruptions included access to care, treatment continuity, hospital admissions, and infection control.

Purpose of the Study:

  • To assess the impact of the COVID-19 pandemic on pediatric cancer care delivery.
  • To understand the challenges faced by pediatric oncologists and their perspectives on future care models.

Main Methods:

  • A survey was distributed to pediatric oncologists across 29 cancer centers in 11 countries.
  • Data was collected from May to August 2020 via direct or internet-based responses.

Main Results:

  • 75.9% of centers reported difficulties in patient access, and 72.4% experienced altered patient flow.
  • 69% of centers reported healthcare worker infections; 62% modified treatment guidelines.
  • Follow-up care was managed via in-hospital visits (27.6%), telemedicine (34.5%), or delays (38%).

Conclusions:

  • The pandemic severely affected pediatric cancer care, necessitating adaptive strategies.
  • Pediatric oncologists anticipate a rise in telemedicine and potential modifications to chemotherapy regimens.
  • Collaborative research is crucial for optimizing pediatric cancer management during and after the pandemic.

More Related Videos

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma09:06

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

Published on: November 11, 2021

2.6K
Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic09:03

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Published on: November 7, 2020

4.9K

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
424
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.3K
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.8K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.2K